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arry A. Latson, MD
leveland, Ohio
he modern technique for balloon pulmonary valvuloplasty
BPV) was described in 1982 (1). Numerous reports over
he past 25 years have shown that BPV uniformly relieves
ulmonary stenosis in patients with the typical isolated
ulmonary valve abnormality. The remarkable safety and
fficacy of this procedure really opened the door to the
evelopment of the specialty of interventional catheteriza-
ion for congenital heart disease. It has also long been
ecognized that patients develop some degree of pulmonary
egurgitation (PR) after BPV, but the prevalence, degree,
nd consequences of the pulmonary regurgitation are far less
ell elucidated. In this issue of the Journal, Harrild et al. (2)
rom Boston report some of the most detailed data to date
n these issues.
See page 1041
The good news from the Boston study is that the typical
egree of PR following BPV is remarkably mild. In a
omewhat select group of patients, median PR fraction was
nly 10%, and median right ventricular (RV) volume was in
he normal range (z-score  1.5) at a median of 13.1 years
ost-BPV. This study excluded patients with significant
esidual pulmonary stenosis, and presumably, any patients
ho may have undergone pulmonary valve replacement
rior to the study. The bad news is that PR can sometimes
e severe. The present study found that 11% (4 of 35) of
PV patients followed in Boston had an RV volume index
-score 4 and an absolute RV volume index140 ml/m2.
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or them
merican College of Cardiology.
From the Cleveland Clinic Foundation, Pediatric Cardiology, Cleveland, Ohio.Not too surprisingly, in the Boston study, the use of an
versized balloon for the BPV was associated with a higher
robability of more severe PR as measured by PR fraction.
erman et al. (3), were among the first to report the need for
ulmonary valve replacement in some patients after BPV
3). They reported in 1999 that 6% of their patients had PR
evere enough to consider pulmonary valve replacement on
linical and qualitative echocardiographic grounds, but did
ot have quantitative data on the degree of PR or RV
olumes. They advised caution in the use of oversized
alloons, especially in neonates and infants with severe
tenosis. The Boston group similarly found that caution is
arranted when considering a balloon to annulus ratio
BAR) 1.4. Inspection of the Boston data and graphs,
owever, shows that the relationship between BAR and
egree of PR for any individual patient was not particularly
trong. A number of patients with BAR 1.4 had PR
raction 20% (a percentage that is commonly used to
enote the boundary between mild and moderate). Inter-
stingly, there were also a number of patients with BAR as
igh as 1.9, but with relatively mild PR fraction. As Harrild
t al. (2) point out, a target BAR of 1.2 to 1.4 seems best,
ut adherence to this target will not guarantee minimal PR.
he Boston study was not designed to address the question
f how to proceed if a patient still has a significant
ost-dilation gradient after BPV with a balloon in the target
ange. The best approach to these patients needs further
tudy.
Much of the cardiac magnetic resonance (CMR) data
rom the Boston study is not unexpected. For instance, one
ould expect a close correlation between PR volume (in-
exed for body size) and PR fraction. There may be some
ebate about whether PR fraction or PR volume is a better
ndex to follow, but they are related (4). It is not too
urprising that PR fraction was not related to duration
etween valvuloplasty and a single CMR study. The degree
f PR at any 1 point in time for an individual patient is more
ikely related to the underlying anatomy and the technical
spects of the valvuloplasty (such as BAR). The Boston
tudy was not designed to study how PR changes over time,
ut it would be interesting to know more about the “natural
istory” of PR progression following BPV. Clinically, PR is
ot very evident in the first months after BPV (perhaps
ecause of RV hypertrophy and low compliance). It is not
ell known whether the PR will reach a certain level and
emain stable, or progress relentlessly with time. The study
lso found that higher PR fraction is correlated with
ounger age at BPV. The study did not find that higher RV
ressure (and intuitively a more abnormal valve) was related
o late PR fraction. The study population spans a wide age
ange (1 day to 27 years) so RV:systemic pressure ratio
ight have given a better indication of relative severity of
tenosis. It is not clear whether the best strategy to avoid late
R may be to wait until an asymptomatic patient with
oderate stenosis is older before performing elective BPV.
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March 9, 2010:1048–9 Balloon Pulmonary ValvuloplastyIn my view, the most uncertain conclusions from the
aper by Harrild et al. (2) involve the relationship of PR to
xercise performance. Exercise capacity is determined by a
arge number of factors, including inherent genetic dif-
erences between individuals, conditioning, motivation,
ethod of testing, and function of the cardiovascular and
espiratory systems. Although some of the technical factors
oncerning repeatability are well controlled because the
tudies were done at a single center, there is no matched
ontrol group and thus no good idea of the variability that
ight be seen in a well-matched normal population. Some
ndex of baseline physical activity might be especially
mportant to consider since sedentary lifestyle can have a
ignificant effect on performance, and tends to be more
ommon in patients with a diagnosis of congenital heart
isease (5). In the author’s analysis, if a patient did not
chieve 85% of a predicted value (determined from a
ifferent study), this was considered abnormal (6). Cer-
ainly, this is a typical strategy for clinical testing, but
oesn’t help us to understand how many children in a typical
lassroom might also not achieve the 85% predicted mark.
he authors note that there was no linear correlation
etween PR fraction and exercise capacity. Indeed, inspec-
ion of the figures shows that the patient with the highest
egurgitant fraction had a peak VO2 of 100% predicted, and
t least 5 patients with peak VO2 85% predicted had very
ittle PR (PR fractions 15%). The authors chose the 15%
egurgitation fraction as an apparent indicator of significant
egurgitation only after evaluating receiver-operator curves.
ven using this approach, and grouping all levels of regur-
itation 15% together, the analysis showed group differ-
nces of 96% predicted compared with 85% predicted to be
ignificantly different only at the p  0.03 level. Peak work
sing this approach was not significantly different between
he groups with PR fraction less than 15% compared with
hose with PR fraction more than 15%.
The study by Harrild et al. (2) certainly does add to our
ody of knowledge regarding the effects of relatively isolated
R on measures of ventricular function and right ventricular
ize. The authors are to be congratulated for prospectively
nrolling 40 (mostly) pediatric research patients to undergo
MR and metabolic exercise studies. The number of
K
vatients, however, is still quite small, and more data are
eeded to better understand how PR interacts with other
actors to affect exercise tolerance (and ultimately long-term
ifestyle and lifespan). In the not-too-distant future, percu-
aneous pulmonary valve replacement may be much more
idely available. It appears that few patients after BPV will
evelop PR significant enough to meet the current criteria
or surgical pulmonary valve replacement after repair of
etralogy of Fallot (RV end-diastolic volume index approx-
mately150/m2). In time, however, there may be a natural
endency to consider percutaneous pulmonary valve replace-
ent with less stringent criteria. More studies like the
arrild et al. (2) study are needed in patients with isolated
ulmonary stenosis before we should begin to consider early
alve replacement as a means to alter or preserve exercise
apacity.
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